Romania vs United States: The number of people with susceptibility test result for rifampicin
Romania
4,366
in 2021
United States
4,814
in 2021
Romania rank
31st
United States rank
30th
The number of people with susceptibility test result for rifampicin over time
- Romania
- United States
How they compare
United States currently reports 4,814 against 4,366 in Romania, a difference of 448.
That makes United States's figure about 1.1 times Romania's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Romania ahead.
Romania ranks 31st and United States ranks 30th of 155 countries.
Across the 2 decades both report, Romania averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | Romania | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,018 | 5,218 | 800 | Romania |
| 2020s | 3,988 | 4,592 | 604.5 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Romania or United States?
- United States, at 4,814 against 4,366 in Romania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Romania and United States?
- 448, with United States ahead.
- How many years of comparable data are there for Romania and United States?
- 5 years are reported by both, from 2017 to 2021.
- How do Romania and United States rank globally for the number of people with susceptibility test result for rifampicin?
- Romania ranks 31st and United States ranks 30th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.